Ceelen Wim, Walder Jean, Cardon Anne, Van Renterghem Katrien, Hesse Uwe, El Malt Mohamed, Pattyn Piet
Department of Abdominal Surgery, Ghent University Hospital, Ghent, Belgium.
Ann Surg. 2003 Jan;237(1):10-6. doi: 10.1097/00000658-200301000-00002.
To evaluate the use of a low-pressure gastric band in the treatment of severe obesity in a prospective study.
Gastric banding for severe obesity has been associated with erosion and perforation of the stomach. The Swedish adjustable gastric band (SAGB) has been proposed as a low-pressure device.
From January 1998 to October 2001, 625 patients underwent laparoscopic SAGB. Median age was 36 years, and 80.4% of patients were female. Median preoperative body mass index (BMI) was 40. Previous upper abdominal surgery was reported in 36 (6%) patients. A five-trocar technique was used without a calibration balloon.
Median follow-up was 19.5 months. All patients were treated laparoscopically with a median operating time of 80 minutes. Conversion was necessary in two patients (0.3%): one trocar injury of the mesentery and one esophageal perforation. Median hospital stay was 3 days; there were no 30-day deaths. Early morbidity was present in 27 patients (4.3%). Late band reoperation was necessary in 49 patients (7.8%). Indications for reoperation were band slippage or pouch dilation, acute total dysphagia, and band leakage or malfunction. Median excess weight loss was 45.8%, 49.9%, and 47.4% after 1, 2, and 3 years, respectively, with a measurable beneficial effect on arterial hypertension, sleep apnea syndrome, and diabetes control.
SAGB is a safe and effective new method in the management of severe obesity. Long-term follow-up (>3 years) is necessary to confirm its effectiveness and safety.
在一项前瞻性研究中评估低压胃束带治疗重度肥胖的应用情况。
重度肥胖的胃束带术与胃糜烂和穿孔有关。瑞典可调节胃束带(SAGB)已被提议作为一种低压装置。
1998年1月至2001年10月,625例患者接受了腹腔镜SAGB手术。中位年龄为36岁,80.4%的患者为女性。术前中位体重指数(BMI)为40。36例(6%)患者曾有上腹部手术史。采用五套管技术,未使用校准球囊。
中位随访时间为19.5个月。所有患者均接受腹腔镜治疗,中位手术时间为80分钟。两名患者(0.3%)需要中转手术:一例肠系膜套管损伤,一例食管穿孔。中位住院时间为3天;无30天死亡病例。27例患者(4.3%)出现早期并发症。49例患者(7.8%)需要进行后期束带再手术。再手术的指征为束带滑脱或胃囊扩张、急性完全吞咽困难以及束带渗漏或故障。1年、2年和3年后的中位超重减轻分别为45.8%、49.9%和47.4%,对动脉高血压、睡眠呼吸暂停综合征和糖尿病控制有明显有益效果。
SAGB是治疗重度肥胖的一种安全有效的新方法。需要长期随访(>3年)以确认其有效性和安全性。